250 related articles for article (PubMed ID: 8353318)
1. Sickle cell disease pathophysiology.
Noguchi CT; Schechter AN; Rodgers GP
Baillieres Clin Haematol; 1993 Mar; 6(1):57-91. PubMed ID: 8353318
[TBL] [Abstract][Full Text] [Related]
2. Intracellular polymerization of sickle hemoglobin: disease severity and therapeutic goals.
Noguchi CT; Rodgers GP; Schechter AN
Prog Clin Biol Res; 1987; 240():381-91. PubMed ID: 3615501
[TBL] [Abstract][Full Text] [Related]
3. Variation in fetal hemoglobin parameters and predicted hemoglobin S polymerization in sickle cell children in the first two years of life: Parisian Prospective Study on Sickle Cell Disease.
Maier-Redelsperger M; Noguchi CT; de Montalembert M; Rodgers GP; Schechter AN; Gourbil A; Blanchard D; Jais JP; Ducrocq R; Peltier JY
Blood; 1994 Nov; 84(9):3182-8. PubMed ID: 7524767
[TBL] [Abstract][Full Text] [Related]
4. Sickle cell disease--pathophysiology, clinical and diagnostic implications.
Dorn-Beineke A; Frietsch T
Clin Chem Lab Med; 2002 Nov; 40(11):1075-84. PubMed ID: 12521222
[TBL] [Abstract][Full Text] [Related]
5. Sickling of nucleated erythroid precursors from patients with sickle cell anemia.
Hasegawa S; Rodgers GP; Dwyer N; Noguchi CT; Blanchette-Mackie EJ; Uyesaka N; Schechter AN; Fibach E
Exp Hematol; 1998 Apr; 26(4):314-9. PubMed ID: 9546314
[TBL] [Abstract][Full Text] [Related]
6. Contributions of sickle hemoglobin polymer and sickle cell membranes to impaired filterability.
Hiruma H; Noguchi CT; Uyesaka N; Schechter AN; Rodgers GP
Am J Physiol; 1995 May; 268(5 Pt 2):H2003-8. PubMed ID: 7771550
[TBL] [Abstract][Full Text] [Related]
7. Sickle cell biomechanics.
Barabino GA; Platt MO; Kaul DK
Annu Rev Biomed Eng; 2010 Aug; 12():345-67. PubMed ID: 20455701
[TBL] [Abstract][Full Text] [Related]
8. Established and experimental treatments for sickle cell disease.
De Franceschi L; Corrocher R
Haematologica; 2004 Mar; 89(3):348-56. PubMed ID: 15020275
[TBL] [Abstract][Full Text] [Related]
9. Hemoglobin S polymerization: primary determinant of the hemolytic and clinical severity of the sickling syndromes.
Brittenham GM; Schechter AN; Noguchi CT
Blood; 1985 Jan; 65(1):183-9. PubMed ID: 3965046
[TBL] [Abstract][Full Text] [Related]
10. Overview of pathophysiology and rationale for treatment of sickle cell anemia.
Rodgers GP
Semin Hematol; 1997 Jul; 34(3 Suppl 3):2-7. PubMed ID: 9317195
[TBL] [Abstract][Full Text] [Related]
11. 2015 Clinical trials update in sickle cell anemia.
Archer N; Galacteros F; Brugnara C
Am J Hematol; 2015 Oct; 90(10):934-50. PubMed ID: 26178236
[TBL] [Abstract][Full Text] [Related]
12. Influence of sickle hemoglobin polymerization and membrane properties on deformability of sickle erythrocytes in the microcirculation.
Dong C; Chadwick RS; Schechter AN
Biophys J; 1992 Sep; 63(3):774-83. PubMed ID: 1420913
[TBL] [Abstract][Full Text] [Related]
13. Promising therapies in sickle cell disease.
Raghupathy R; Billett HH
Cardiovasc Hematol Disord Drug Targets; 2009 Mar; 9(1):1-8. PubMed ID: 19275572
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiology of sickle cell disease.
Steinberg MH
Baillieres Clin Haematol; 1998 Mar; 11(1):163-84. PubMed ID: 10872477
[TBL] [Abstract][Full Text] [Related]
15. Insight into the complex pathophysiology of sickle cell anaemia and possible treatment.
Piccin A; Murphy C; Eakins E; Rondinelli MB; Daves M; Vecchiato C; Wolf D; Mc Mahon C; Smith OP
Eur J Haematol; 2019 Apr; 102(4):319-330. PubMed ID: 30664257
[TBL] [Abstract][Full Text] [Related]
16. Fetal hemoglobin in sickle cell anemia: a glass half full?
Steinberg MH; Chui DH; Dover GJ; Sebastiani P; Alsultan A
Blood; 2014 Jan; 123(4):481-5. PubMed ID: 24222332
[TBL] [Abstract][Full Text] [Related]
17. Fetal haemoglobin levels and haematological characteristics of compound heterozygotes for haemoglobin S and deletional hereditary persistence of fetal haemoglobin.
Ngo DA; Aygun B; Akinsheye I; Hankins JS; Bhan I; Luo HY; Steinberg MH; Chui DH
Br J Haematol; 2012 Jan; 156(2):259-64. PubMed ID: 22017641
[TBL] [Abstract][Full Text] [Related]
18. The clinical pathophysiology of sickle cell disease.
Embury SH
Annu Rev Med; 1986; 37():361-76. PubMed ID: 2423018
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiologically based drug treatment of sickle cell disease.
Steinberg MH
Trends Pharmacol Sci; 2006 Apr; 27(4):204-10. PubMed ID: 16530854
[TBL] [Abstract][Full Text] [Related]
20. Determination of sickle hemoglobin polymer in SS and AS erythrocytes.
Noguchi CT; Torchia DA; Schechter AN
Blood Cells; 1982; 8(2):225-35. PubMed ID: 7159747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
